You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Details for Patent: 9,108,975


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,108,975 protect, and when does it expire?

Patent 9,108,975 protects SYMPROIC and is included in one NDA.

This patent has forty-two patent family members in twenty-five countries.

Summary for Patent: 9,108,975
Title:Crystal of 6,7-unsaturated-7-carbamoyl morphinan derivative and method for producing the same
Abstract: Stable crystalline forms of a compound represented by the formula (IA): ##STR00001## an acid addition salt, and/or a solvate thereof are provided by the present invention. Said crystalline forms are extremely useful as materials for preparing medicines. Novel processes for preparing 6,7-unsaturated-7-carbamoyl morphinan derivatives are also provided by the present invention.
Inventor(s): Tamura; Yoshinori (Toyonaka, JP), Noguchi; Kouichi (Amagasaki, JP), Inagaki; Masanao (Toyonaka, JP), Morimoto; Kenji (Toyonaka, JP), Haga; Nobuhiro (Toyonaka, JP), Oda; Shinichi (Iwate-ken, JP), Omura; Sohei (Amagasaki, JP)
Assignee: Shionogi & Co., LTD. (Osaka, JP)
Application Number:13/884,770
Patent Claim Types:
see list of patent claims
Composition; Compound;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 9,108,975

Introduction

Patents are a crucial component of intellectual property, providing inventors and companies with exclusive rights to their innovations. The scope and claims of a patent are essential in defining what is protected and what is not. This article will delve into the details of United States Patent 9,108,975, analyzing its scope, claims, and the broader patent landscape.

What is United States Patent 9,108,975?

United States Patent 9,108,975, though not specifically detailed in the provided sources, can be analyzed using general principles of patent law and the structure of patent documents.

Patent Scope and Claims

The scope of a patent is determined by its claims, which are the legally binding descriptions of the invention. Here are some key points to consider:

Independent and Dependent Claims

Patents typically include both independent and dependent claims. Independent claims stand alone and define the invention in broad terms, while dependent claims build upon the independent claims and provide more specific details[3].

Claim Language and Metrics

The language used in claims is critical. Metrics such as independent claim length and independent claim count can be used to measure patent scope. Narrower claims, often indicated by shorter lengths and fewer counts, are generally associated with a higher probability of grant and a shorter examination process[3].

Analyzing the Claims of US Patent 9,108,975

To analyze the claims of this patent, one would need to review the patent document itself. Here are the steps involved:

Identifying Independent Claims

Look for the independent claims, which are usually the broadest claims in the patent. These claims define the core of the invention.

Understanding Dependent Claims

Dependent claims will refer back to the independent claims and add additional limitations or details. These claims help to narrow down the scope of the invention.

Claim Construction

Claim construction involves interpreting the meaning of the claims. This is a critical step in determining the scope of the patent and is often a point of contention in patent litigation.

Patent Examination Process

The examination process plays a significant role in shaping the final scope of a patent. Here are some key points:

Narrowing of Claims

During the examination process, claims may be narrowed to overcome objections from the patent office. This can result in a more focused and specific scope for the patent[3].

Forward Citations and Patent Maintenance

The number of forward citations (citations by later patents) and patent maintenance payments can also indicate the scope and importance of a patent. Patents with narrower claims at publication tend to have a higher probability of grant and shorter examination processes[3].

Broader Patent Landscape

Understanding the broader patent landscape is essential for contextualizing the scope and claims of US Patent 9,108,975.

Patent Trends and Quality

Debates over patent quality often revolve around the breadth and clarity of patent claims. There is a concern that overly broad patents can stifle innovation due to increased licensing and litigation costs[3].

Small Claims Patent Court

There have been discussions about establishing a small claims patent court to address issues related to patent litigation costs and complexity. This could impact how patents are enforced and the strategies companies use to protect their intellectual property[5].

Expiring Patents and Market Impact

Patents have a limited lifespan, and their expiration can significantly impact the market. For example, several drug patents are set to expire in 2026, which could lead to the entry of generic drugs into the market[4].

Key Takeaways

  • Claims Define Scope: The claims in a patent are the definitive descriptions of what is protected.
  • Claim Metrics: Independent claim length and count can be used to measure patent scope.
  • Examination Process: The patent examination process can narrow the scope of claims.
  • Broader Landscape: Understanding broader patent trends and potential changes in patent law is crucial for strategic planning.
  • Market Impact: Expiring patents can significantly affect market dynamics.

FAQs

Q: What determines the scope of a patent? A: The scope of a patent is determined by its claims, which are the legally binding descriptions of the invention.

Q: How do independent and dependent claims differ? A: Independent claims stand alone and define the invention in broad terms, while dependent claims build upon the independent claims and provide more specific details.

Q: What metrics can be used to measure patent scope? A: Metrics such as independent claim length and independent claim count can be used to measure patent scope.

Q: How does the patent examination process affect the scope of claims? A: During the examination process, claims may be narrowed to overcome objections from the patent office, resulting in a more focused and specific scope for the patent.

Q: What is the significance of forward citations and patent maintenance payments? A: Forward citations and patent maintenance payments can indicate the scope and importance of a patent, with narrower claims at publication often associated with a higher probability of grant and shorter examination processes.

Sources

  1. Improved Synthesis of Naldemedine Tosylate and Related Compounds - HETEROCYCLES, Vol. 105, No. 1, 2022.
  2. Patent Claims Research Dataset - USPTO.
  3. Patent Claims and Patent Scope - SSRN.
  4. List - 55 Drug Patents Expiring in 2026 - GreyB.
  5. U.S. Patent Small Claims Court - ACUS.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,108,975

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Bdsi SYMPROIC naldemedine tosylate TABLET;ORAL 208854-001 Mar 23, 2017 RX Yes Yes 9,108,975 ⤷  Subscribe Y Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 9,108,975

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan2010-253688Nov 12, 2010
PCT Information
PCT FiledNovember 11, 2011PCT Application Number:PCT/JP2011/076034
PCT Publication Date:May 18, 2012PCT Publication Number: WO2012/063933

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.